SCHEMBL5197966

SCHEMBL5197966

CCOC(=O)N1CCC(C2(O)c3cc(C)ccc3CC2(C)C)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.46
ALOX12 P18054 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NOS3 P29474 1/20 0.44
NOS1 P29475 1/20 0.44
NOS2 P35228 1/20 0.44
MDM2 Q00987 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 3/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
TP53 P04637 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14430365 0.89 ALDH1A1 (0.44) GAAL3MBTL1KMT2AHTTTDP1
SCHEMBL5199209 0.83 MAPK1 (0.42) SMN1; SMN2L3MBTL1POLBKMT2ACYP3A4
SCHEMBL14430493 0.82 POLB (0.35) SMN1; SMN2L3MBTL1POLBKMT2AHTT
SCHEMBL5199517 0.77 MAPK1 (0.40) SMN1; SMN2L3MBTL1POLBKMT2A
SCHEMBL14430366 0.76 L3MBTL1 (0.45) SMN1; SMN2NOS2L3MBTL1KMT2AMEN1
SCHEMBL5199648 0.75 SIGMAR1 (0.45) GAAPOLBLMNA
SCHEMBL14430370 0.74 ALDH1A1 (0.41) GAASMN1; SMN2L3MBTL1POLBRAB9A
SCHEMBL5199965 0.74 KDM1A (0.38) POLBKMT2AMEN1CYP3A4
SCHEMBL14430432 0.74 MAPK1 (0.41) SMN1; SMN2L3MBTL1KMT2ACYP3A4
SCHEMBL14430600 0.73 POLB (0.33) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197594-A1 Cyclic amine derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2007-08-23 US disclosed
US-20070197594-A1 Cyclic amine derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2007-08-23 US disclosed
US-20070197594-A1 Cyclic amine derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2007-08-23 US disclosed
EP-1795524-A1 CYCLIC AMINE DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2007-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197594-A1 Cyclic amine derivative or salt thereof GRIN1, PARK7, GRIN3A GAA 2797/4885ALOX12 589/4885SMN1; SMN2 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.